| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| USD | 750.000 | 7 | Sep-31 | Sr. Unsecured | B3 | B+ | - | Fixed | Tsy | Mid to High 8s | 8.25-8.50% | 446 | 8.25% | - | 100.00000 |
Tranche Comments
7 yr: Redemption: 2027-09-01; Registration: 144A/Reg S; Comments: USD750m 7yr(9/1/2031) cpn 8.25% at 100. T+446bps vs 4.125% 07/31/31. NC3 (09/01/27) (MWC: T+50bps), then at 104.125, 102.063, 100. CoC: 101%. Equity claw: 3y 35% at 108.25;
Use of Proceeds
Refinancing
| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| CSI | 624.000 | 6 | Nov-95 | Hv. Koqocovon | T3 | Y+ | - | Wyupk | Ubm | - | 10.25-10.50% | 806 | 10.50% | - | 748.00000 |
Tranche Comments
8 st: Registration: 144O/Fda N; Comments: IR$500p 8-bnhr xp3 ynxpjr nxynpnrns xjsn jaanrpxn aph YVIK(rnas)/YID/YVPDNX/YHZH/INR;
Use of Proceeds
Owceu uymwg